Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Burley

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|October 31, 2022
A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancerAmy Burley, Antonio Rullan, Anna Wilkins
The Journal of Pathology|July 24, 2024
TP53 mutations in urothelial carcinoma: not all one and the same<sup>†</sup>Alexis R Barr, Amy Burley, Anna Wilkins
Cancer Journal (Sudbury, Mass.)|August 6, 2025
Targeting Cancer-associated Fibroblasts (CAFs) to Optimize Radiation ResponsesKatie O'Fee, Amy Burley, Sarah Stewart, et al.
Nature Reviews. Urology|August 21, 2023
The sex gap in bladder cancer survival - a missing link in bladder cancer care?Paul Toren, Anna Wilkins, Keval Patel, et al.
Science Translational Medicine|April 16, 2025
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemiaNicola Maciocia, Malika Hoekx, Ciaran Acuna, et al.
Blood|May 4, 2022
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemiaPaul M Maciocia, Patrycja A Wawrzyniecka, Nicola C Maciocia, et al.
Nature Communications|August 12, 2024
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapyEmmanuel C Patin, Pablo Nenclares, Charleen Chan Wah Hak, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|October 31, 2022
A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancerAmy Burley, Antonio Rullan, Anna Wilkins
The Journal of Pathology|July 24, 2024
TP53 mutations in urothelial carcinoma: not all one and the same<sup>†</sup>Alexis R Barr, Amy Burley, Anna Wilkins
Cancer Journal (Sudbury, Mass.)|August 6, 2025
Targeting Cancer-associated Fibroblasts (CAFs) to Optimize Radiation ResponsesKatie O'Fee, Amy Burley, Sarah Stewart, et al.
Nature Reviews. Urology|August 21, 2023
The sex gap in bladder cancer survival - a missing link in bladder cancer care?Paul Toren, Anna Wilkins, Keval Patel, et al.
Science Translational Medicine|April 16, 2025
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemiaNicola Maciocia, Malika Hoekx, Ciaran Acuna, et al.
Blood|May 4, 2022
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemiaPaul M Maciocia, Patrycja A Wawrzyniecka, Nicola C Maciocia, et al.
Nature Communications|August 12, 2024
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapyEmmanuel C Patin, Pablo Nenclares, Charleen Chan Wah Hak, et al.
Pageof 1